Christopher R. Fenimore - Feb 9, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Christopher R. Fenimore
Stock symbol
REGN
Transactions as of
Feb 9, 2024
Transactions value $
-$4,689,320
Form type
4
Date filed
2/12/2024, 04:02 PM
Previous filing
Jan 25, 2024
Next filing
Aug 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$327K -344 -1.78% $950.49 18.9K Feb 9, 2024 Direct F1
transaction REGN Common Stock Sale -$463K -487 -2.57% $951.39 18.5K Feb 9, 2024 Direct F2
transaction REGN Common Stock Sale -$996K -1.05K -5.67% $952.62 17.4K Feb 9, 2024 Direct F3
transaction REGN Common Stock Sale -$1.28M -1.34K -7.71% $953.47 16.1K Feb 9, 2024 Direct F4
transaction REGN Common Stock Sale -$1.05M -1.1K -6.84% $954.57 15K Feb 9, 2024 Direct F5
transaction REGN Common Stock Sale -$573K -600 -4.01% $955.00 14.4K Feb 9, 2024 Direct
holding REGN Common Stock 1.47K Feb 9, 2024 2021 GRAT
holding REGN Common Stock 4.27K Feb 9, 2024 2022 GRAT
holding REGN Common Stock 1.5K Feb 9, 2024 By 401(k) Plan
holding REGN Common Stock 1.9K Feb 9, 2024 By Trust F6
holding REGN Common Stock 461 Feb 9, 2024 by Trust for Daugh
holding REGN Common Stock 460 Feb 9, 2024 by Trust for Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 344 shares of Company stock on February 9, 2024 at prices ranging from $950.33 to $950.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
F2 Represents volume-weighted average price of sales of 487 shares of Company stock on February 9, 2024 at prices ranging from $951.03 to $951.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
F3 Represents volume-weighted average price of sales of 1,046 shares of Company stock on February 9, 2024 at prices ranging from $952.11 to $952.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
F4 Represents volume-weighted average price of sales of 1,342 shares of Company stock on February 9, 2024 at prices ranging from $953.02 to $953.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
F5 Represents volume-weighted average price of sales of 1,100 shares of Company stock on February 9, 2024 at prices ranging from $954.00 to $954.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
F6 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.